Hi,
moomoo ID:NaN
Log Out
ENGLISH
  • ENGLISH
  • 中文繁体
  • 中文简体
donwloadimg

Download App

Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data

REGN Regeneron Pharmaceuticals

697.330
+9.070+1.32%
Close 09/23 16:00 ET
697.010
-0.320-0.05%
Post Mkt Price 09/23 18:40 ET
High
699.370
Open
685.800
Turnover
564.74M
Low
681.000
Pre Close
688.260
Volume
815.88K
Market Cap
76.01B
P/E(TTM)
13.95
52wk High
754.670
Shares
109.01M
P/E(Static)
9.69
52wk Low
538.010
Float Cap
72.23B
Bid/Ask %
0.00%
Historical High
754.670
Shs Float
103.58M
Volume Ratio
0.97
Historical Low
4.610
Dividend TTM
--
Div Yield TTM
1300
P/B
3.67
Dividend LFY
--
Div Yield LFY
186.43%
Turnover Ratio
0.79%
Amplitude
2.67%
Avg Price
692.186
Lot Size
1
Float Cap
72.23B
Bid/Ask %
0.00%
Historical High
754.670
Shs Float
103.58M
Volume Ratio
0.97
Historical Low
4.610
Dividend TTM
--
P/B
3.67
Dividend LFY
--
Turnover Ratio
0.79%
Amplitude
2.67%
Avg Price
692.186
Lot Size
1
Price Forecast

No Data

News

Comment

No More
Company Overview More
Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. Its product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The firm accelerates the traditional drug development process through its proprietary VelociSuite technologies such as VelocImmune, which uses unique genetically-humanized mice to produce optimized fully-human antibodies and bispecific antibodies. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988, and is headquartered in Tarrytown, NY.
CEO: Dr. Leonard S. Schleifer,M.D.,PhD
Market: NASDAQ
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...